Skip to content
Screener

Pulse Biosciences, Inc. PLSE Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

LivaNova logo
LivaNovaLIVN
$6.66M+50.0%
Abbott logo
AbbottABT
Boston Scientific logo
Boston ScientificBSX
AtriCure logo
AtriCureATRC
Medtronic logo
MedtronicMDT
AngioDynamics logo
AngioDynamicsANGO

Other financials

Income statement

See full
Revenue$434.0K
Gross profit$161.0K
Operating income-$25.3M-24.6%
Net income-$24.7M-28.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$101.6M-4.4%
Total debt$6.8M-17.9%
Total equity$99.5M-4.8%
Total assets$115.6M-3.9%

Cash flow

See full
Operating cash flow-$18.7M-46.1%
CapEx$90.0K-12.6%
Free cash flow-$18.8M-45.6%

Valuation

See full
Market cap$2.96B+196%
Enterprise value$2.87B+217%
P/S2,498.4×

Profitability

See full
Gross margin-0.1%
Operating margin-7,007.8%
Net margin-6,755.8%
FCF margin-5,180.4%

Returns & leverage

See full
Return on equity-78.5%-15.3pp
Debt / equity0.1×0.0×
Current ratio9.6×-2.4×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437749-26-026288
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Net loss$(43,238)$(35,963)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation176223
Amortization of intangible assets333333
Stock-based compensation6,88510,870
Non-cash lease expense625556
Write-off of deferred issuance costs281
Other74

Document

FAQ

What is Pulse Biosciences, Inc.'s amortization of capitalized software and acquired intangible assets?
Pulse Biosciences, Inc. (PLSE) reported amortization of capitalized software and acquired intangible assets of $166K in Q2 2026.
How has Pulse Biosciences, Inc.'s amortization of capitalized software and acquired intangible assets changed year-over-year?
Pulse Biosciences, Inc.'s amortization of capitalized software and acquired intangible assets decreased by 0.6% year-over-year, from $167K to $166K.
What is the long-term trend for Pulse Biosciences, Inc.'s amortization of capitalized software and acquired intangible assets?
Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s amortization of capitalized software and acquired intangible assets has grown at a -0.0% compound annual growth rate (CAGR), from $666K to $665K.
What does amortization of capitalized software and acquired intangible assets mean?
Amortization of capitalized software and acquired intangible assets

Ask your AI about Pulse Biosciences, Inc.'s amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude